More Country-Level Action, Research Into New Antibiotics Needed To Address Resistance, Experts Say

TIME: It’s Been One Year Since the World Took On Superbugs. Here’s What’s Changed
“…Since the 2016 meeting, more meetings and committees have been formed to tackle [antimicrobial resistance (AMR)] and provide recommendations on the global and national level. The WHO has urged countries to develop a national action plan on the issue. Currently, 85 percent of member countries are developing or have developed a plan, but only five percent of countries have developed an AMR action plan that addresses multiple sectors and has been implemented with funding sources and monitoring processes…” (Sifferlin, 9/22).

WIRED: The post-antibiotic era is here. Now what?
“…Just last week, the World Health Organization released a report analyzing all the antibacterial agents currently in clinical development. Its conclusions were grim: not enough drugs, not enough innovation. There’s already some amount of pre-existing resistance to just about every one of the 51 treatments coming down the line. … The antibiotic age might be over. But there’s still a lot to say about what comes next” (Molteni, 9/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.